Recent studies have highlighted the benefits of stress cardiac MRI testing in diagnosing microvascular angina and improving patient quality of life, especially in cases of suspected angina with no obstructive coronary arteries. Additionally, Lantern Pharma is leveraging AI technology to revolutionize cancer drug development, with a focus on personalized treatments and faster, more cost-effective therapies.